Available studies (208 found)

Filter citations (author, year, title, ID)
Data type for full-text extraction
Short citationFull citationBioassayEpidemiologyEpi. meta-analysisIn vitroEcology
Akahori et al. 2008 Akahori Y, Nakai M, Yamasaki K, Takatsuki M, Shimohigashi Y, Ohtaki M. 2008. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: Comparative study with 65 selected chemicals. Toxicol In Vitro 22:225-231. PubMed
Amoco Corporation 1991a Amoco Corporation. 1991. CHO/HGPRT mutation assay (final report) with attachment and cover letter dated 111491. EPA/OTS. 920000118:#86-920000118.
Amoco Corporation 1991b Amoco Corporation. 1991. Chromosome aberrations in chinese hamster ovary (CHO) cells (final report) with attachment and cover letter dated 111491. EPA/OTS. 920000119:#86-920000119.
Anonymous 1954a Anonymous. 1954. Table V toxicity tests. Chemical Biological Coordination Center, Summary Biological Tests, National Research Council 6:138-149.
Anonymous 1954b Anonymous. 1954. Table V toxicity tests. Chemical Biological Coordination Center, Summary Biological Tests, National Research Council 6:138-149.
Asano et al. 2002 Asano K, Ono A, Hashimoto S, Inoue T, Kanno J. 2002. Screening method of endocrine disrupting chemicals using a surface plasmon resonance sensor. Bunseki Kagaku. 51:389-396. PubMed
Ashcroft et al. 2011 Ashcroft FJ, Newberg JY, Jones ED, Mikic I, Mancini MA. 2011. High content imaging-based assay to classify estrogen receptor-alpha ligands based on defined mechanistic outcomes. Gene 477:42-52. PubMed DOI
Audebert et al. 2011 Audebert, M, Dolo, L, Perdu, E, et al. 2011. Use of the gammaH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch Toxicol 85:1463-1473. PubMed DOI
Bayer 1992 Bayer. 1992. Salmonella/microsome test (final report) with cover letter dated 042392. EPA/OTS. 920000911:#86-920000911.
Bermudez et al. 2010 Bermudez DS, Gray LE Jr., Wilson VS. 2010. Modeling the interaction of binary and ternary mixtures of estradiol with bisphenol A and bisphenol AF in an in vitro estrogen-mediated transcriptional activation assay (T47D-KBluc). Toxicol Sci 116:477-487. PubMed DOI
Bitman and Cecil 1970 Bitman J, Cecil HC. 1970. Estrogenic activity of ddt analogs and polychlorinated biphenyls. J Agr Food Chem 18:1108-1112. PubMed
Blair et al. 2000 Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, et al. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol Sci 54:138-153. PubMed
Bruze 1985a Bruze M, Zimerson E. 1985. Contact allergy to dihydroxydiphenyl methanes (bisphenol F). Dermatosen Beruf Umwelt 33(6):216-20. PubMed
Bruze 1986 Bruze M. 1986. Sensitizing capacity of dihydroxydiphenylmethane (bisphenol F) in the guinea pig. Contact Dermatitis 14(4):228-32. PubMed
Butt and Stapelton 2013 Butt CM, Stapleton HM. 2013. Inhibition of thyroid hormone sulfotransferase activity by brominated flame retardants and halogenated phenolics [10.1021/tx400342k]. Chem Res Toxicol 26(11). PubMed DOI
Butt et al. 2011 Butt CM, Wang D, Stapleton HM. 2011. Halogenated phenolic contaminants inhibit the in vitro activity of the thyroid-regulating deiodinases in human liver. Toxicol Sci 124:339-347. PubMed DOI
Cabaton et al. 2008 Cabaton N, Zalko D, Rathahao E, Canlet C, Delous G, Cagnon MC, Cravedi JP, Perdu E, et al. 2008. Biotransformation of bisphenol F by human and rat liver subcellular fractions. Toxicol In Vitro 22:1697-1704. PubMed DOI
Cabaton et al. 2009 Cabaton N, Dumont C, Severin I, et al. 2009. Genotoxic and endocrine activities of bis(hydroxyphenyl)methane (bisphenol F) and its derivatives in the HepG2 cell line. Toxicology 255:15-24. PubMed DOI
Campbell 1941 Campbell NR. 1941. Molecular structure in relation to oestrogenic activity: Derivatives of 4:4'-dihydroxydiphenylmethane. Proc R Soc Lond B Biol Sci 129(857):528-538.
Chen et al. 2002 Chen MY, Ike M, Fujita M. 2002. Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ Toxicol 17:80-86. PubMed
Coleman et al. 2003 Coleman KP, Toscano WA, Jr., Wiese TE. 2003. QSAR models of the in vitro estrogen activity of bisphenol A analogs. QSAR Comb Sci 22:78-88.
Delfosse et al. 2012 Delfosse V, Grimaldi M, Pons JL, et al. 2012. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc Natl Acad Sci U S A 109:14930-14935. PubMed DOI
Dodds & Lawson 1936 Dodds EC, Lawson W. 1936. Synthetic oestrogenic agents without the phenathrene nucleus. Nature 137(3476):996-996.
Dodds & Lawson 1938 Dodds EC, Lawson W. 1938. Molecular structure in relation to oestrogenic activity: Compounds without a phenathrene nucleus. Proc R Soc Lond B Biol Sci 125(839):222-232.
Dring et al. 2010 Dring AM, Anderson LE, Qamar S, et al. 2010. Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands. Chem Biol Interact 188:512-525. PubMed DOI

Showing studies 1-25 of 208